• News
  • SAN DIEGO
  • BioTech

Obesity drug maker Arena books smaller 3Q loss

San Diego-based weight loss drugmaker Arena Pharmaceuticals Inc. (Nasdaq: ARNA) said Tuesday that its third-quarter loss shrank as its research and development and manufacturing costs declined.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Arena Pharmaceuticals Inc.

Company Website

6166 Nancy Ridge Drive
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ARNA
4.56
  -0.21  
- 4.40%
4,746,126,000
7.36
3.26

Insider Trade Data

Date Insider Shares Type Value
01/08/2015 Spector, Steven W 45,000 Exchange $277,200
01/08/2015 Spector, Steven W 45,000 Sell $281,700
01/08/2015 Spector, Steven W 45,000 Exchange $277,200
01/08/2015 Spector, Steven W 45,000 Sell $281,700
01/07/2015 Shanahan, William R Jr 50,000 Exchange $74,500

Arena Pharmaceuticals Inc. Executive(s):

Jack Lief

  • Chief Executive Officer, President, Chairman

Similar Companies

NAICS - 424210 - Drugs and Druggists' Sundries Merchant Wholesalers
SIC - 5122 - DRUGS, DRUG PROPRIETARIES, AND DRUGGISTS' SUNDRIES
NAICS - 541711 - Research and Development in Biotechnology
SIC - 8731 - COMMERCIAL PHYSICAL AND BIOLOGICAL RESEARCH
SIC - 8733 - NONCOMMERCIAL RESEARCH ORGANIZATIONS
Subscribe Today!